marketcap
Facebook
Twitter
Telegram
Report an ErrorSeneca Biopharma, Inc. Balance Sheet 2011-2024 | SNCA
Annual Balance Sheet Seneca Biopharma, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-10.5 M | -4.7 M | -5.79 M | -6.67 M | -11.5 M | 3.31 M | -3.73 M | -9.15 M | -7.44 M | -2.35 M |
Long Term Debt |
- | - | - | - | - | 3.39 M | 8.06 M | 4.93 M | - | - |
Total Non Current Liabilities |
- | 233 K | 584 K | 3.85 M | 3.94 M | 3.57 M | 8.12 M | 5.06 M | 21.1 K | - |
Total Current Liabilities |
3.21 M | 1.22 M | 1.05 M | 1.51 M | 7.33 M | 6.52 M | 4.01 M | 5.94 M | 1.76 M | 2.43 M |
Total Liabilities |
3.28 M | 1.46 M | 1.63 M | 5.37 M | 11.3 M | 10.1 M | 12.1 M | 11 M | 1.78 M | 2.43 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | -222 M | -214 M | -209 M | -193 M | -172 M | -151 M | -128 M | -109 M | -98.5 M |
Total Assets |
13 M | 6.58 M | 7.68 M | 13.9 M | 22.6 M | 15 M | 29.8 M | 19.4 M | 8.75 M | 4.09 M |
All numbers in USD currency